mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.8 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |